EUVIMEDEUVIMED entdecken
Multizentrische Studie

Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan

Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Tomonori Kambayshi, Satoshi Kano iD, Takahiro Kusaka, Daisuke Matsushita, Kosuke Murayama, Yuya Miyakura, Satoshi Kubota, Ryosuke Sato, Shino Godo und 5 weitere

Japanese Journal of Clinical Oncology · 2025

DOI: 10.1093/jjco/hyaf147 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Akira Ohkoshi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 98…. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment of unresectable salivary gland cancers is challenging. This multicenter, retrospective study aimed to evaluate the treatment outcomes of definitive radiotherapy, with or without chemotherapy, for locally advanced, unresectable, salivary gland cancers.

Methods

A total of 27 patients with unresectable salivary gland cancers who underwent concurrent chemoradiotherapy or radiotherapy with curative intent between 2012 and 2022 at 13 hospitals in northern Japan were included in this study. Overall survival (OS) and progression-free survival (PFS) were assessed, and factors affecting OS and PFS were identified through univariate and multivariate Cox regression analyses. The variables evaluated included age, sex, primary site, histological type, clinical T and N status, clinical stage, treatment type, and radiation type.

Results

Seven patients received concurrent chemoradiotherapy, and 20 patients received radiotherapy (6 photon, 11 proton, 3 heavy ion). With a median follow-up period of 28 months, the three-year OS and PFS rates for the 27 patients were 54.4% and 27.8%, respectively. Patients who received concurrent chemoradiotherapy had better PFS than those who received radiotherapy alone (HR 0.16, 95% CI 0.03–0.81, P = .026).

Conclusions

Definitive radiotherapy for locally advanced, unresectable, salivary gland cancers resulted in relatively good outcomes. Concurrent chemoradiotherapy was associated with better PFS than radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedJapanTreatment OutcomeAdultAged, 80 and overChemoradiotherapySurvival Rate

Stichwörter der Autor:innen

concurrent chemoradiotherapyhead and neck cancerradiotherapysalivary gland cancer

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.
  • Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 8, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-0808, Japan.
  • Department of Otolaryngology - Head and Neck Surgery, Iwate Medical University School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate Prefecture 028-3694, Japan.
  • Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, 53 Honcho, Hirosaki, Aomori 036-8563, Japan.
  • Department of Otolaryngology - Head and Neck Surgery, Sapporo Medical University, 16-291 Minami 1jo-nishi, Chuo-ku, Sapporo 060-8543, Japan.
  • Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1 Nodayama, Medeshimashiode, Natori, Miyagi 981-1293, Japan.

ORCID-Profile: Satoshi Kano

Zitieren

APA

Ohkoshi, A., Ishii, R., Higashi, K., Kambayshi, T., Kano, S., Kusaka, T., Matsushita, D., Murayama, K., Miyakura, Y., Kubota, S., Sato, R., Godo, S., Tomizawa, H., Toyoma, S., Tagawa, A., Shirotori, A., & Katori, Y. (2025). Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf147

Vancouver

Ohkoshi A, Ishii R, Higashi K, Kambayshi T, Kano S, Kusaka T, et al. Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyaf147

BibTeX
@article{Ohkoshi2025,
  author = {Ohkoshi, Akira and Ishii, Ryo and Higashi, Kenjiro and Kambayshi, Tomonori and Kano, Satoshi and Kusaka, Takahiro and Matsushita, Daisuke and Murayama, Kosuke and Miyakura, Yuya and Kubota, Satoshi and Sato, Ryosuke and Godo, Shino and Tomizawa, Hiroki and Toyoma, Satoshi and Tagawa, Ai and Shirotori, Akina and Katori, Yukio},
  title = {Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1093/jjco/hyaf147}
}
Kostenlos starten →